Bruce & Co
Latest statistics and disclosures from Bruce & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ABBV, ALL, AER, NextEra Energy, Merck & Co, and represent 37.05% of Bruce & Co's stock portfolio.
- Added to shares of these 4 stocks: SUPN, BBNX, FATE, AER.
- Reduced shares in these 10 stocks: VICR (-$6.5M), UHAL.B, ALL, AAPL, NextEra Energy, ABBV, Merck & Co, CMS, XEL, ABT.
- Bruce & Co was a net seller of stock by $-7.1M.
- Bruce & Co has $370M in assets under management (AUM), dropping by 5.67%.
- Central Index Key (CIK): 0001358331
Tip: Access up to 7 years of quarterly data
Positions held by Bruce & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bruce & Co
Bruce & Co holds 41 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Abbvie Common (ABBV) | 8.2 | $30M | 121k | 251.64 |
|
|
| Allstate Common (ALL) | 7.9 | $29M | -2% | 123k | 237.94 |
|
| AerCap Holdings Common (AER) | 7.3 | $27M | 185k | 145.78 |
|
|
| Nextera Energy Common | 7.0 | $26M | 294k | 87.77 |
|
|
| Merck Common | 6.6 | $25M | 191k | 128.50 |
|
|
| Uhaul B Common (UHAL.B) | 6.5 | $24M | -7% | 417k | 57.70 |
|
| Duke Energy Common (DUK) | 5.0 | $18M | 145k | 126.58 |
|
|
| Vicor Common (VICR) | 4.9 | $18M | -26% | 48k | 379.78 |
|
| XCEL Energy Common (XEL) | 4.0 | $15M | 183k | 80.30 |
|
|
| CMS Energy Common (CMS) | 3.2 | $12M | 153k | 76.50 |
|
|
| At & T Common (T) | 2.9 | $11M | 518k | 20.70 |
|
|
| Apple Common (AAPL) | 2.9 | $11M | -5% | 37k | 289.36 |
|
| Beta Bionics Common (BBNX) | 2.8 | $10M | +20% | 666k | 15.67 |
|
| Insteel Common (IIIN) | 2.8 | $10M | 343k | 30.20 |
|
|
| Abbott Common (ABT) | 2.8 | $10M | 112k | 90.74 |
|
|
| Newmont Common (NEM) | 2.5 | $9.3M | 100k | 93.40 |
|
|
| Avista Common (AVA) | 2.2 | $8.2M | 200k | 40.91 |
|
|
| Archer Daniels Common (ADM) | 2.1 | $7.6M | 100k | 76.40 |
|
|
| Bunge Common (BG) | 2.0 | $7.5M | 70k | 106.73 |
|
|
| Supernus Common (SUPN) | 1.9 | $7.0M | +50% | 150k | 46.51 |
|
| Pfizer Common (PFE) | 1.7 | $6.5M | 268k | 24.08 |
|
|
| Darling Ingredients Common (DAR) | 1.6 | $5.7M | 105k | 54.62 |
|
|
| Kodiak Sciences Common (KOD) | 1.5 | $5.6M | 145k | 38.96 |
|
|
| Chemours Common (CC) | 1.4 | $5.1M | 250k | 20.52 |
|
|
| Uhaul Common (UHAL) | 1.3 | $4.8M | 73k | 65.44 |
|
|
| Lyondellbasell Common (LYB) | 0.9 | $3.2M | 60k | 52.65 |
|
|
| Personalis Common (PSNL) | 0.8 | $3.1M | 233k | 13.40 |
|
|
| Fate Theraputics Common (FATE) | 0.7 | $2.7M | +25% | 989k | 2.70 |
|
| Eli Lilly Common (LLY) | 0.6 | $2.4M | 2.0k | 1199.43 |
|
|
| Rli Common (RLI) | 0.6 | $2.4M | 40k | 59.07 |
|
|
| Apogee Common (APOG) | 0.6 | $2.3M | 50k | 45.74 |
|
|
| FocalTherics Common (FOCL) | 0.6 | $2.3M | 439k | 5.18 |
|
|
| XM Sirius Common | 0.4 | $1.6M | 56k | 29.54 |
|
|
| Venture Global Common (VG) | 0.3 | $1.1M | 100k | 11.13 |
|
|
| Ashland Common | 0.3 | $988k | 15k | 65.89 |
|
|
| Viatris Common (VTRS) | 0.2 | $916k | 58k | 15.88 |
|
|
| Mannkind Common (MNKD) | 0.2 | $831k | 195k | 4.26 |
|
|
| Bausch Health Common | 0.2 | $611k | 124k | 4.93 |
|
|
| 908 Devices Common (MASS) | 0.2 | $594k | 68k | 8.70 |
|
|
| WEC Energy Common (WEC) | 0.1 | $461k | 3.9k | 116.77 |
|
|
| Caribou Biosciences Common (CRBU) | 0.1 | $440k | 250k | 1.76 |
|
Past Filings by Bruce & Co
SEC 13F filings are viewable for Bruce & Co going back to 2010
- Bruce & Co 2026 Q2 filed Aug. 14, 2026
- Bruce & Co 2026 Q1 filed May 14, 2026
- Bruce & Co 2025 Q4 filed Feb. 13, 2026
- Bruce & Co 2025 Q3 filed Nov. 13, 2025
- Bruce & Co 2025 Q2 filed Aug. 14, 2025
- Bruce & Co 2025 Q1 filed May 14, 2025
- Bruce & Co 2024 Q4 filed Feb. 11, 2025
- Bruce & Co 2024 Q3 filed Nov. 14, 2024
- Bruce & Co 2024 Q2 filed Aug. 9, 2024
- Bruce & Co 2024 Q1 filed May 13, 2024
- Bruce & Co 2023 Q4 filed Feb. 12, 2024
- Bruce & Co 2023 Q3 filed Nov. 13, 2023
- Bruce & Co 2023 Q2 filed Aug. 8, 2023
- Bruce & Co 2023 Q1 filed May 12, 2023
- Bruce & Co 2022 Q4 filed Feb. 15, 2023
- Bruce & Co 2022 Q3 filed Nov. 15, 2022